Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 4
Submit an article Journal homepage
75
Views
8
CrossRef citations to date
0
Altmetric
Focused Reviews in CML

New therapeutic approaches and prognostic factors in chronic myeloid leukemia

Giuseppe Saglio Division of Haematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Turin, ItalyCorrespondence[email protected]
,
Stefano Ulisciani Division of Haematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy
,
Marco Bosa Division of Haematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy
,
Daniela Cilloni Division of Haematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy
&
Giovanna Rege-Cambrin Division of Haematology and Internal Medicine, Department of Clinical and Biological Sciences of the University of Turin, Turin, Italy
Pages 625-628 | Published online: 01 Jul 2009

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jiahuai Tan, Shundong Cang, Karen Seiter, Suneeta Primanneni, Nasir Ahmed, Thomas Mathews & Delong Liu. (2009) t(3;9;22) 3-Way Chromosome Translocation in Chronic Myeloid Leukemia is Associated with Poor Prognosis. Cancer Investigation 27:7, pages 718-722.
Read now

Articles from other publishers (7)

E Hadzijusufovic, K Albrecht-Schgoer, K Huber, G Hoermann, F Grebien, G Eisenwort, W Schgoer, S Herndlhofer, C Kaun, M Theurl, W R Sperr, U Rix, I Sadovnik, B Jilma, G H Schernthaner, J Wojta, D Wolf, G Superti-Furga, R Kirchmair & P Valent. (2017) Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. Leukemia 31:11, pages 2388-2397.
Crossref
Miao Gao, Zheng-Lan Huang, Kun Tao, Qing Xiao, Xin Wang, Wei-Xi Cao, Min Xu, Jing Hu & Wen-Li Feng. (2016) Depression of oncogenecity by dephosphorylating and degrading BCR-ABL. Oncotarget 8:2, pages 3304-3314.
Crossref
Peter Valent, Günther Gastl, Klaus Geissler, Richard Greil, Oliver Hantschel, Alois Lang, Werner Linkesch, Thomas Lion, Andreas L. Petzer, Elisabeth Pittermann, Lisa Pleyer, Josef Thaler & Dominik Wolf. (2012) Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: Open questions. Critical Reviews in Oncology/Hematology 82:3, pages 370-377.
Crossref
Karl J. Aichberger, Susanne Herndlhofer, Gerit‐Holger Schernthaner, Martin Schillinger, Gerlinde Mitterbauer‐Hohendanner, Christian Sillaber & Peter Valent. (2011) Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML. American Journal of Hematology 86:7, pages 533-539.
Crossref
Susanne Schnittger, Ulrike Bacher, Frank Dicker, Wolfgang Kern, Tamara Alpermann, Torsten Haferlach & Claudia Haferlach. (2010) Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML. Genes, Chromosomes and Cancer 49:10, pages 910-918.
Crossref
Jae-Sook AhnYeo-Kyeoung KimSe Ryeon LeeLi YuDeok-Hwan YangSang-Hee ChoHyun Jeong ShimWoo Kyun BaeJe-Jung LeeIk-Joo ChungMyung Gun ShinHyeoung-Joon Kim. (2010) Coexisting with Clonal Evolution and BCR-ABL Mutant in CML Patients Treated with Second-generation Tyrosine Kinase Inhibitors Predict the Discrepancy of in vitro Drug Sensitivity. Cancer Research and Treatment 42:1, pages 37.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.